Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 1 | 40.2% |
| Consulting Fee | $3,740 | 3 | 37.6% |
| Food and Beverage | $1,711 | 66 | 17.2% |
| Education | $293.80 | 6 | 3.0% |
| Travel and Lodging | $209.71 | 4 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $8,025 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $418.40 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $279.45 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $255.51 | 22 | $0 (2019) |
| Blue Earth Diagnostics Limited | $172.34 | 3 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $110.33 | 6 | $0 (2018) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Janssen Products, LP | $99.00 | 1 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $98.61 | 2 | $0 (2017) |
| ABBVIE INC. | $96.88 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.22 | 6 | ABBVIE INC. ($79.21) |
| 2023 | $104.62 | 4 | Astellas Pharma US Inc ($57.91) |
| 2019 | $2,436 | 11 | Janssen Scientific Affairs, LLC ($2,229) |
| 2018 | $2,459 | 34 | Janssen Scientific Affairs, LLC ($1,743) |
| 2017 | $4,790 | 25 | Janssen Scientific Affairs, LLC ($4,053) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Urology | ||||||
| 01/18/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Urology | ||||||
| 12/09/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/07/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Diagnostic Imaging | ||||||
| 06/30/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Oncology | ||||||
| 02/25/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Urology | ||||||
| 10/12/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Hyperparathyroidism | ||||||
| 10/11/2019 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2019 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
| 05/01/2019 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Consulting Fee | Cash or cash equivalent | $2,060.00 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Travel and Lodging | Cash or cash equivalent | $43.82 | General |
| Category: Oncology | ||||||
| 03/26/2019 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: Oncology | ||||||
| 02/28/2019 | Janssen Pharmaceuticals, Inc | Erleada (Drug) | Education | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 01/31/2019 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: CONTINENCE | ||||||
| 01/10/2019 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Oncology | ||||||
| 12/12/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: Diagnostic Imaging | ||||||
| 11/07/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 11/01/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $59.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,362 | 2,079 | $567,537 | $140,201 |
| 2022 | 13 | 1,176 | 1,736 | $451,096 | $116,095 |
| 2021 | 15 | 1,268 | 1,893 | $531,186 | $134,362 |
| 2020 | 20 | 1,130 | 1,640 | $513,279 | $118,504 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 438 | $180,018 | $47,511 | 26.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 74 | 105 | $84,840 | $23,661 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 81 | $45,117 | $12,848 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 171 | $47,367 | $12,352 | 26.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 84 | $46,452 | $11,389 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $27,305 | $6,440 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $25,504 | $6,240 | 24.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 401 | 655 | $8,425 | $5,461 | 64.8% |
| 55706 | Needle biopsy of prostate gland using image guidance | Facility | 2023 | 13 | 13 | $19,136 | $4,033 | 21.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 223 | 347 | $26,719 | $3,395 | 12.7% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 11 | 14 | $14,658 | $1,582 | 10.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $10,296 | $1,487 | 14.4% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 12 | 12 | $17,508 | $1,270 | 7.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 32 | $4,064 | $1,005 | 24.7% |
| 45990 | Diagnostic exam of anus and rectum under anesthesia | Facility | 2023 | 14 | 16 | $7,152 | $830.24 | 11.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 23 | 24 | $2,976 | $695.52 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 305 | $125,355 | $31,919 | 25.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 66 | 98 | $79,184 | $22,561 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 245 | $67,865 | $18,292 | 27.0% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2022 | 11 | 11 | $30,019 | $8,870 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 50 | $27,850 | $8,315 | 29.9% |
| 55706 | Needle biopsy of prostate gland using image guidance | Facility | 2022 | 22 | 22 | $32,384 | $8,066 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $23,910 | $6,058 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $22,225 | $5,234 | 23.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 189 | 306 | $23,562 | $3,008 | 12.8% |
About Dr. Mitchell Benson, MD
Dr. Mitchell Benson, MD is a Urology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518060425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Benson, MD has received a total of $9,955 in payments from pharmaceutical and medical device companies, with $165.22 received in 2024. These payments were reported across 80 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,000).
As a Medicare-enrolled provider, Benson has provided services to 4,936 Medicare beneficiaries, totaling 7,348 services with total Medicare billing of $509,162. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location New York, NY
- Active Since 09/06/2006
- Last Updated 06/17/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1518060425
Products in Payments
- Erleada (Drug) $4,126
- DARZALEX (Biological) $4,000
- NO PRODUCT DISCUSSED (Drug) $279.45
- ZYTIGA (Drug) $220.65
- Axumin (Drug) $143.30
- XTANDI (Drug) $129.67
- KEYTRUDA (Biological) $129.12
- Myrbetriq (Drug) $117.41
- Xofigo (Drug) $110.33
- GREENLIGHT (Device) $98.61
- BOTOX (Biological) $96.88
- Rayaldee (Drug) $80.74
- Xtandi (Drug) $79.57
- ARN-509 (Biological) $52.97
- ELIGARD (Drug) $37.67
- POSLUMA (Drug) $29.04
- SPEEDICATH (Device) $22.09
- PROVENGE (Drug) $21.95
- Valleylab FT10 (Device) $19.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in New York
Mr. Michael Grasso, Md, MD
Urology — Payments: $742,907
Robert Valenzuela, Md, MD
Urology — Payments: $642,070
Dr. Neil Bander, M.d, M.D
Urology — Payments: $540,525
Dr. Benjamin Brucker, Md, MD
Urology — Payments: $454,774
Katie Murray, D.o, D.O
Urology — Payments: $367,085
Dr. Ketan Badani, M.d, M.D
Urology — Payments: $308,393